ConductScience.org, home

Paper · 16632607

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
41944163Transgenic mouse models for investigating human DUX4 expression during development and its roles in FSHD pathophysiology.Dis Model Mech2026https://conductscience.org/library/papers/41944163PubMed
367554933D genome alterations and editing in pathology.Mol Ther2023https://conductscience.org/library/papers/36755493PubMed
32121044Does DNA Methylation Matter in FSHD?Genes (Basel)2020https://conductscience.org/library/papers/32121044PubMed
31316120Analysis of the 4q35 chromatin organization reveals distinct long-range interactions in patients affected with Facio-Scapulo-Humeral Dystrophy.Sci Rep2019https://conductscience.org/library/papers/31316120PubMed
31265077Mapping of scaffold/matrix attachment regions in human genome: a data mining exercise.Nucleic Acids Res2019https://conductscience.org/library/papers/31265077PubMed
310974734q-D4Z4 chromatin architecture regulates the transcription of muscle atrophic genes in facioscapulohumeral muscular dystrophy.Genome Res2019https://conductscience.org/library/papers/31097473PubMed
27722032PARP1 Differentially Interacts with Promoter region of DUX4 Gene in FSHD Myoblasts.J Genet Syndr Gene Ther2016https://conductscience.org/library/papers/27722032PubMed
272867203D genomics imposes evolution of the domain model of eukaryotic genome organization.Chromosoma2017https://conductscience.org/library/papers/27286720PubMed
26942723Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).PLoS One2016https://conductscience.org/library/papers/26942723PubMed
26860865Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.Histochem Cell Biol2016https://conductscience.org/library/papers/26860865PubMed
26184877ZNF555 protein binds to transcriptional activator site of 4qA allele and ANT1: potential implication in Facioscapulohumeral dystrophy.Nucleic Acids Res2015https://conductscience.org/library/papers/26184877PubMed
25789155DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.Skelet Muscle2014https://conductscience.org/library/papers/25789155PubMed
25715743Eukaryotic enhancers: common features, regulation, and participation in diseases.Cell Mol Life Sci2015https://conductscience.org/library/papers/25715743PubMed
25336259Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.Antioxid Redox Signal2015https://conductscience.org/library/papers/25336259PubMed
25323867Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.Curr Mol Med2014https://conductscience.org/library/papers/25323867PubMed
24940479Facioscapulohumeral dystrophy: the path to consensus on pathophysiology.Skelet Muscle2014https://conductscience.org/library/papers/24940479PubMed
24636994Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.Mol Cell Biol2014https://conductscience.org/library/papers/24636994PubMed
24448543DNA polymorphism and epigenetic marks modulate the affinity of a scaffold/matrix attachment region to the nuclear matrix.Eur J Hum Genet2014https://conductscience.org/library/papers/24448543PubMed
24145033Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.J Biol Chem2013https://conductscience.org/library/papers/24145033PubMed
23852133TM6, a novel nuclear matrix attachment region, enhances its flanking gene expression through influencing their chromatin structure.Mol Cells2013https://conductscience.org/library/papers/23852133PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/16632607/cited_by